Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bruzzi

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
British Journal of Cancer|June 23, 2005
HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patientsL Del Mastro, P Bruzzi, G Nicolò, et al.
Journal of Cellular Biochemistry|January 5, 2000
Assessment of DNA flow cytometry as a surrogate end point biomarker in a bladder cancer chemoprevention trialS Bruno, R Torrisi, M Costantini, et al.
Sarcoma|June 4, 2008
Lack of Activity of Docetaxel in Soft Tissue Sarcomas: Results of a Phase II Study of the Italian Group on Rare TumorsA Santoro, A Romanini, A Rosso, et al.
Cancer|August 16, 2001
Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP)H S Parra, L Tixi, F Latteri, et al.
Breast (Edinburgh, Scotland)|April 1, 2017
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysisF Poggio, M Ceppi, M Lambertini, et al.
International Journal of Cancer|October 3, 1999
Characterization of ligurian melanoma families and risk of occurrence of other neoplasiaP Ghiorzo, P Ciotti, M Mantelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studiesM Lambertini, M Ceppi, F Poggio, et al.
Tumori|July 30, 1999
The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: a phase III randomized FONICAP trial. Italian Lung Cancer Task ForceF De Marinis, M Rinaldi, A Ardizzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2007
Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine aloneS Novello, P Bruzzi, C Barone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2000
Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end pointA Decensi, R Torrisi, S Bruno, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
British Journal of Cancer|June 23, 2005
HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patientsL Del Mastro, P Bruzzi, G Nicolò, et al.
Journal of Cellular Biochemistry|January 5, 2000
Assessment of DNA flow cytometry as a surrogate end point biomarker in a bladder cancer chemoprevention trialS Bruno, R Torrisi, M Costantini, et al.
Sarcoma|June 4, 2008
Lack of Activity of Docetaxel in Soft Tissue Sarcomas: Results of a Phase II Study of the Italian Group on Rare TumorsA Santoro, A Romanini, A Rosso, et al.
Cancer|August 16, 2001
Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP)H S Parra, L Tixi, F Latteri, et al.
Breast (Edinburgh, Scotland)|April 1, 2017
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysisF Poggio, M Ceppi, M Lambertini, et al.
International Journal of Cancer|October 3, 1999
Characterization of ligurian melanoma families and risk of occurrence of other neoplasiaP Ghiorzo, P Ciotti, M Mantelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studiesM Lambertini, M Ceppi, F Poggio, et al.
Tumori|July 30, 1999
The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: a phase III randomized FONICAP trial. Italian Lung Cancer Task ForceF De Marinis, M Rinaldi, A Ardizzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2007
Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine aloneS Novello, P Bruzzi, C Barone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2000
Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end pointA Decensi, R Torrisi, S Bruno, et al.
Pageof 17